The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
Open accessAbstract
Summary: CD26/DPP4 (dipeptidyl peptidase 4/DP4/DPPIV) is a surface T cell activation antigen and has been shown to have DPP4 enzymatic activity, cleaving-off amino-terminal dipeptides with either L-proline or L-alanine at the penultimate position. It plays a major role in glucose metabolism by N-terminal truncation and inactivation of the incretins glucagon-like peptide-1 (GLP) and gastric inhibitory protein (GIP). In 2006, DPP4 inhibitors have been introduced to clinics and have been demonstrated to efficiently enhance the endogenous insulin secretion via prolongation of the half-life of GLP-1 and GIP in patients. However, a large number of studies demonstrate clearly that CD26/DPP4 also plays an integral role in the immune system, particularly in T cell activation. Therefore, inhibition of DPP4 might represent a double-edged sword. Apart from the metabolic benefit, the associated immunological effects of long term DPP4 inhibition on regulatory processes such as T cell homeostasis, maturation and activation are not understood fully at this stage. The current data point to an important role for CD26/DPP4 in maintaining lymphocyte composition and function, T cell activation and co-stimulation, memory T cell generation and thymic emigration patterns during immune-senescence. In rodents, critical immune changes occur at baseline levels as well as after in-vitro and in-vivo challenge. In patients receiving DPP4 inhibitors, evidence of immunological side effects also became apparent. The scope of this review is to recapitulate the role of CD26/DPP4 in the immune system regarding its pharmacological inhibition and T cell-dependent immune regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
Severini, C., Improta, G., Falconieri-Erspamer, G., Salvadori, S., & Erspamer, V. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.285 · Cited by 637
Asthma: an epidemic of dysregulated immunity
Umetsu, D. T., McIntire, J. J., Akbari, O., Macaubas, C., & DeKruyff, R. H. (2002) · Nature Immunology · doi:10.1038/ni0802-715 · Cited by 599
Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26
Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., & Morimoto, C. (1993) · Science · doi:10.1126/science.8101391 · Cited by 507
Pancreatic safety of incretin-based drugs–FDA and EMA assessment
Egan, A. G., Blind, E., Dunder, K., de Graeff, P. A., Hummer, B. T., Bourcier, T., & Rosebraugh, C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1314078 · Cited by 498
Butler, A. E., Campbell-Thompson, M., Gurlo, T., Dawson, D. W., Atkinson, M., & Butler, P. C. (2013) · Diabetes · doi:10.2337/db12-1686 · Cited by 457
CD26, let it cut or cut it down
De Meester, I., Korom, S., Van Damme, J., & Scharpé, S. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01486-3 · Cited by 451
Röhrborn, D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00386 · Cited by 440
A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-?-naphthylamide
Hopsu-Havu, V. K., & Glenner, G. G. (1966) · Histochemie · doi:10.1007/bf00577838 · Cited by 435
Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog
Rasmussen, H. B., Branner, S., Wiberg, F. C., & Wagtmann, N. (2003) · Nature Structural Biology · doi:10.1038/nsb882 · Cited by 424
The structure and function of CD26 in the T‐cell immune response
Morimoto, C., & Schlossman, S. F. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01571.x · Cited by 421
BARNETT, A. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01178.x · Cited by 391
Shah, Z., Kampfrath, T., Deiuliis, J. A., Zhong, J., Pineda, C., Ying, Z., Xu, X., Lu, B., Moffatt-Bruce, S., Durairaj, R., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.041418 · Cited by 377
Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
(2014) · New England Journal of Medicine · doi:10.1056/nejmx140026 · Cited by 372
CD26: A Multifunctional Integral Membrane and Secreted Protein of Activated Lymphocytes
Gorrell, M. D., Gysbers, V., & McCaughan, G. W. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00984.x · Cited by 363
The multifunctional or moonlighting protein CD26/DPPIV
Boonacker, E., & Van Noorden, C. J. F. (2003) · European Journal of Cell Biology · doi:10.1078/0171-9335-00302 · Cited by 337
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
GORRELL, M. D. (2005) · Clinical Science · doi:10.1042/cs20040302 · Cited by 334
Hale, J. S., Boursalian, T. E., Turk, G. L., & Fink, P. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601040103 · Cited by 322
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
Richter, B., Bandeira-Echtler, E., Bergerhoff, K., & Lerch, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006739.pub2 · Cited by 308
Engel, M., Hoffmann, T., Wagner, L., Wermann, M., Heiser, U., Kiefersauer, R., Huber, R., Bode, W., Demuth, H.-U., & Brandstetter, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230620100 · Cited by 305
Self-citationNatural killer cell cytotoxicity: how do they pull the trigger?
Topham, N. J., & Hewitt, E. W. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03123.x · Cited by 298
Durinx, C., Lambeir, A., Bosmans, E., Falmagne, J., Berghmans, R., Haemers, A., Scharpé, S., & De Meester, I. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01634.x · Cited by 267
Pederson, R. A., White, H. A., Schlenzig, D., Pauly, R. P., McIntosh, C. H. S., & Demuth, H.-U. (1998) · Diabetes · doi:10.2337/diab.47.8.1253 · Cited by 267
Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Yazbeck, R., Howarth, G. S., & Abbott, C. A. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.003 · Cited by 241
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function
Ohnuma, K., Dang, N. H., & Morimoto, C. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.02.010 · Cited by 238
Rosenstock, J., Sankoh, S., & List, J. F. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00876.x · Cited by 234
Aertgeerts, K., Ye, S., Tennant, M. G., Kraus, M. L., Rogers, J., Sang, B., Skene, R. J., Webb, D. R., & Prasad, G. S. (2004) · Protein Science · doi:10.1110/ps.03460604 · Cited by 210
Pharmacology of Dipeptidyl Peptidase-4 Inhibitors: Similarities and Differences
Baetta, R., & Corsini, A. (2011) · Drugs · doi:10.2165/11591400-000000000-00000 · Cited by 209
Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme
Matteucci, E., & Giampietro, O. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803114 · Cited by 204
Cloning and functional expression of the T cell activation antigen CD26
Tanaka, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.2090 · Cited by 202
DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials
Scheen, A. J. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.11.001 · Cited by 200
On the origin of serum CD26 and its altered concentration in cancer patients
Cordero, O. J., Salgado, F. J., & Nogueira, M. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0728-1 · Cited by 198
Waumans, Y., Baerts, L., Kehoe, K., Lambeir, A.-M., & De Meester, I. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00387 · Cited by 194
Type 2 diabetes—Therapy with dipeptidyl peptidase IV inhibitors
Demuth, H.-U., McIntosh, C. H. S., & Pederson, R. A. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.05.010 · Cited by 192
Circulating CD26 Is Negatively Associated with Inflammation in Human and Experimental Arthritis
Busso, N., Wagtmann, N., Herling, C., Chobaz-Péclat, V., Bischof-Delaloye, A., So, A., & Grouzmann, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62266-3 · Cited by 191
Piazza, G. A., Callanan, H. M., Mowery, J., & Hixson, D. C. (1989) · Biochemical Journal · doi:10.1042/bj2620327 · Cited by 178
Cloning and functional expression of the T cell activation antigen CD26
Tanaka, T., Camerini, D., Seed, B., Torimoto, Y., Dang, N. H., Kameoka, J., Dahlberg, H. N., Schlossman, S. F., & Morimoto, C. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.481 · Cited by 178
Abbott, C. A., McCaughan, G. W., Baker, E., & Sutherland, G. R. (1994) · Immunogenetics · doi:10.1007/bf01246674 · Cited by 177
The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S. F., & Morimoto, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4586 · Cited by 176
Zhong, J., Rao, X., Deiuliis, J., Braunstein, Z., Narula, V., Hazey, J., Mikami, D., Needleman, B., Satoskar, A. R., & Rajagopalan, S. (2013) · Diabetes · doi:10.2337/db12-0230 · Cited by 176
Ishii, T., Ohnuma, K., Murakami, A., Takasawa, N., Kobayashi, S., Dang, N. H., Schlossman, S. F., & Morimoto, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211439098 · Cited by 172
Human Th17 Cells Express High Levels of Enzymatically Active Dipeptidylpeptidase IV (CD26)
Bengsch, B., Seigel, B., Flecken, T., Wolanski, J., Blum, H. E., & Thimme, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103801 · Cited by 169
The Safety of Incretin-Based Therapies—Review of the Scientific Evidence
Drucker, D. J., Sherman, S. I., Bergenstal, R. M., & Buse, J. B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0599 · Cited by 150
Neumiller, J. J. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.09078 · Cited by 146
Marney, A. M., Kunchakarra, S., Byrne, L. M., & Brown, N. J. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.156554 · Cited by 146
Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis
Engel, S. S., Williams‐Herman, D., Golm, G. T., Clay, R. J., Machotka, S. V., Kaufman, K. D., & Goldstein, B. J. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02382.x · Cited by 143
The Cysteine-Rich Region of Dipeptidyl Peptidase IV (CD 26) Is the Collagen Binding Site
Löster, K., Zeilinger, K., Schuppan, D., & Reutter, W. G. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2782 · Cited by 143
Willemen, M. J. C., Mantel-Teeuwisse, A. K., Straus, S. M. J. M., Meyboom, R. H., Egberts, T. C. G., & Leufkens, H. G. M. (2011) · Diabetes Care · doi:10.2337/dc10-1771 · Cited by 141
Caveolin-1 Triggers T-cell Activation via CD26 in Association with CARMA1
Ohnuma, K., Uchiyama, M., Yamochi, T., Nishibashi, K., Hosono, O., Takahashi, N., Kina, S., Tanaka, H., Lin, X., Dang, N. H., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609157200 · Cited by 140
Steinbrecher, A., Reinhold, D., Quigley, L., Gado, A. M., Tresser, N. J., Izikson, L., Born, I., Faust, J., Neubert, K., Martinꝉ, R., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2041 · Cited by 138
Animal models of asthma: value, limitations and opportunities for alternative approaches
Holmes, A. M., Solari, R. C. E., & Holgate, S. T. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.014 · Cited by 137
A Novel Consensus Motif in Fibronectin Mediates Dipeptidyl Peptidase IV Adhesion and Metastasis
Cheng, H.-C., Abdel‐Ghany, M., & Pauli, B. U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303424200 · Cited by 133
High expression of CD26 accurately identifies human bacteria‐reactive MR1‐restricted MAIT cells
Sharma, P. K., Wong, E. B., Napier, R. J., Bishai, W. R., Ndung’u, T., Kasprowicz, V. O., Lewinsohn, D. A., Lewinsohn, D. M., & Gold, M. C. (2015) · Immunology · doi:10.1111/imm.12461 · Cited by 126
Ikushima, H., Munakata, Y., Ishii, T., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8439 · Cited by 119
Forssmann, U., Stoetzer, C., Stephan, M., Kruschinski, C., Skripuletz, T., Schade, J., Schmiedl, A., Pabst, R., Wagner, L., Hoffmann, T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1120 · Cited by 115
Self-citationHoffmann, T., Faust, J., Neubert, K., & ANSORGE, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81609-4 · Cited by 115
Direct evidence for the binding of rat liver DPP IV to collagen in vitro
HANSKI, C., Huhle, T., Gossrau, R., et al. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90378-3 · Cited by 115
Wagner, L., Klemann, C., Stephan, M., et al. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12757 · Cited by 114
Self-citationGirardi, A. C. C., Knauf, F., Demuth, H., & Aronson, P. S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00186.2004 · Cited by 112
Functional role of CD26 on human B lymphocytes
Bühling, F., Junker, U., Reinhold, D., Neubert, K., Jäger, L., & Ansorge, S. (1995) · Immunology Letters · doi:10.1016/0165-2478(94)00230-o · Cited by 112
Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease
Xiao, Q., Boushey, R. P., Cino, M., Drucker, D. J., & Brubaker, P. L. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.4.r1057 · Cited by 111
Åhrén, B., & Hughes, T. E. (2004) · Endocrinology · doi:10.1210/en.2004-1174 · Cited by 108
Comodulation of CXCR4 and CD26 in Human Lymphocytes
Herrera, C., Morimoto, C., Blanco, J., Mallol, J., Arenzana‐Seisdedos, F., Lluís, C., & Franco, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004586200 · Cited by 104
Hildebrandt, M., Reutter, W. G., Arck, P., Rose, M., & Klapp, B. F. (2000) · Clinical Science · doi:10.1042/cs0990093 · Cited by 104
Dipeptidyl Peptidase IV in Human T Lymphocytes
Schön, E., Demuth, H., Eichmann, E., et al. (1989) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1989.tb01108.x · Cited by 103
Mortier, A., Gouwy, M., Damme, J. V., Proost, P., & Struyf, S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0915-401r · Cited by 103
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
Richter, B., Bandeira-Echtler, E., Bergerhoff, K., & Ebrahim, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006739 · Cited by 99
Extracellular matrix proteins in intrathymic T-cell migration and differentiation?
Savino, W., Villa‐Verde, D. M. S., & Lannes-Vieira, J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90278-s · Cited by 98
Yan, S., Marguet, D., Dobers, J., Reutter, W. G., & Fan, H. (2003) · European Journal of Immunology · doi:10.1002/eji.200323469 · Cited by 97
Development of structural kidney damage in spontaneously hypertensive rats
Hultström, M. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328352b89a · Cited by 96
Mishriky, B. M., Cummings, D. M., & Tanenberg, R. J. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.025 · Cited by 95
Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP
Mentlein, R. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.005 · Cited by 94
Schade, J., Stephan, M., Schmiedl, A., Wagner, L., Niestroj, A. J., Demuth, H., Frerker, N., Klemann, C., Raber, K. A., Pabst, R., et al. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.7a7319.2007 · Cited by 92
Self-citationBöhm, S. K., Gum, J. R., Erickson, R. H., Hicks, J. W., & Kim, Y. S. (1995) · Biochemical Journal · doi:10.1042/bj3110835 · Cited by 89
Hatano, R., Ohnuma, K., Yamamoto, J., Dang, N. H., & Morimoto, C. (2012) · Immunology · doi:10.1111/imm.12028 · Cited by 89
Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells.
Bühling, F., Kunz, D., Reinhold, D., et al. (1995) · PubMed · Cited by 87
Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels
Hong, W., Petell, J. K., Swank, D. M., Sanford, J. P., Hixson, D. C., & Doyle, D. J. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90296-6 · Cited by 84
Casey, T. M., Meade, J. L., & Hewitt, E. W. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600365-mcp200 · Cited by 82
Dang, N. H., Torimoto, Y., Shimamura, K., et al. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.2825 · Cited by 81
Fan, H., Meng, W., Kilian, C., Grams, S., & Reutter, W. G. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00243.x · Cited by 81
Preller, V., Gerber, A., Wrenger, S., Togni, M., Marguet, D., Tadje, J., Lendeckel, U., Röcken, C., Faust, J., Neubert, K., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4632 · Cited by 80
Dipeptidyl Peptidase IV (DP IV, CD26) in Patients with Inflammatory Bowel Disease
Hildebrandt, M. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750422675 · Cited by 80
Efficacy and safety of incretin-based therapies: Clinical trial data
White, J. R. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.09079 · Cited by 74
Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells
Bauvois, B., Djavaheri‐Mergny, M., Rouillard, D., Dumont, J., & Wietzerbin, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203292 · Cited by 74
Regional Expression of Epithelial Dipeptidyl Peptidase IV in the Human Intestines
Darmoul, D., Voisin, T., Couvineau, A., Rouyer‐Fessard, C., Salomon, R., Wang, Y., Swallow, D. M., & Laburthe, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2313 · Cited by 73
Cuchacovich, M., Gatica, H., Pizzo, S. V., et al. (2002) · PubMed · Cited by 71
Ikushima, H., Munakata, Y., Iwata, S., Ohnuma, K., Kobayashi, S., Dang, N. H., & Morimoto, C. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00010-2 · Cited by 70
Dipeptidyl peptidase in autoimmune pathophysiology
Ohnuma, K., Hosono, O., Dang, N. H., & Morimoto, C. (2011) · Advances in clinical chemistry · doi:10.1016/b978-0-12-385855-9.00003-5 · Cited by 69
Expression of the rat CD26 Antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes
Gorrell, M. D., Wickson, J. E., & McCaughan, G. W. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90343-a · Cited by 69
EFFECTS OF DIPEPTIDYL PEPTIDASE IV INHIBITION ON ARTERIAL BLOOD PRESSURE
Jackson, E. K., Dubinion, J. H., & Mi, Z. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04737.x · Cited by 69
Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia
Röhnert, P., Schmidt, W., Emmerlich, P., Goihl, A., Wrenger, S., Bank, U., Nordhoff, K., Täger, M., Ansorge, S., Reinhold, D., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-44 · Cited by 67
Devin, J. K., Pretorius, M., Nian, H., Yu, C., Billings, F. T., & Brown, N. J. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02767 · Cited by 67
Soluble DPP4 originates in part from bone marrow cells and not from the kidney
Wang, Z., Grigo, C., Steinbeck, J., von Hörsten, S., Amann, K., & Daniel, C. (2014) · Peptides · doi:10.1016/j.peptides.2014.05.006 · Cited by 64
Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus
van der Velden, J., Wierenga‐Wolf, Adriaansen‐Soeting, Overbeek, Møller, J. E., Hoogsteden, & Versnel (1998) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1998.00198.x · Cited by 63
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus
Pitocco, D., Giubilato, S., Martini, F., Zaccardi, F., Pazzano, V., Manto, A., Cammarota, G., Stasio, E. D., Pedicino, D., Liuzzo, G., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.042 · Cited by 63
Reinhold, D., Bank, U., Bühling, F., Täger, M., Born, I., Faust, J., Neubert, K., & Ansorge, S. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)02716-8 · Cited by 63
T-cell activation via CD26 and caveolin-1 in rheumatoid synovium
Ohnuma, K., Inoue, H., Uchiyama, M., Yamochi, T., Hosono, O., Dang, N. H., & Morimoto, C. (2006) · Modern Rheumatology · doi:10.1007/s10165-005-0452-4 · Cited by 63
CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model
Kruschinski, C., Skripuletz, T., Bedoui, S., Tschernig, T., Pabst, R., Nassenstein, C., Braun, A. C., & von Hörsten, S. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02666.x · Cited by 63
Durinx, C., Neels, H. M., der Auwera, J.-C. V., Naelaerts, K., Scharpé, S., & Meester, I. D. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.026 · Cited by 61
Reinhold, D. (2007) · Frontiers in bioscience · doi:10.2741/2849 · Cited by 60
Karl, T., Hoffmann, T., Pabst, R., & von Hörsten, S. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00229-4 · Cited by 59
Fibroblast activation protein expression in Crohnʼs disease strictures
Rovedatti, L., Sabatino, A. D., Knowles, C. H., Sengupta, N., Biancheri, P., Corazza, G. R., & MacDonald, T. T. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21446 · Cited by 59
Grouzmann, E., Monod, M., Landis, B. N., Wilk, S., Brakch, N., Nicoucar, K., Giger, R., Malis, D. D., Szalay‐Quinodoz, I., Cavadas, C., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0939fje · Cited by 59
Bedoui, S., Kuhlmann, S., Nave, H., Drube, J., Pabst, R., & von Hörsten, S. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00328-9 · Cited by 58
Reinhold, D., Hemmer, B., Gran, B., Born, I., Faust, J., Neubert, K., McFarland, H. F., Martinꝉ, R., & Ansorge, S. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00100-3 · Cited by 57
DPP4 inhibitor-induced polyarthritis: a report of three cases
Crickx, É., Marroun, I., Veyrie, C., Beller, C. L., Schoindre, Y., Bouilloud, F., Blétry, O., & Kahn, J. (2013) · Rheumatology International · doi:10.1007/s00296-013-2710-7 · Cited by 56
Krakauer, M., Sørensen, P. S., & Sellebjerg, F. T. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.09.006 · Cited by 56
Riemann, D., Kehlen, A., & Langner, J. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03665.x · Cited by 55
Cheng, D., Fei, Y., Liu, Y., Li, J., Chen, Y., Wang, X., & Wang, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111543 · Cited by 54
DPPIV, seprase, and related serine peptidases in multiple cellular functions
Chen, W., Kelly, T. J., & Ghersi, G. (2003) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(03)54010-8 · Cited by 53
CD26: A negative selection marker for human Treg cells
Salgado, F. J., Pérez, A. C., Villanueva, N. M., Lamas, O., Arias, P., & Nogueira, M. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22117 · Cited by 53
Chromatin, epigenetics and stem cells
Roloff, T. C., & Nuber, U. A. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2004.12.013 · Cited by 53
Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice
Yazbeck, R. (2008) · Frontiers in bioscience · doi:10.2741/3193 · Cited by 52
Kehlen, A., Göhring, B., Langner, J., & Riemann, D. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00513.x · Cited by 51
Enrichment for a CD26hi SIRP− subset in lymph dendritic cells from the upper aero-digestive tract
Epardaud, M., Bonneau, M., Payot, F., Cordier, C., Megret, J., Howard, C. J., & Schwartz-Cornil, I. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404223 · Cited by 51
Vora, K. A., Porter, G., Peng, R., Cui, Y., Pryor, K. D., Eiermann, G. J., & Zaller, D. M. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-19 · Cited by 50
Karl, T., Chwalisz, W. T., Wedekind, D., Hedrich, H. J., Hoffmann, T., Jacobs, R., Pabst, R., & von Hörsten, S. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00149-6 · Cited by 50
CD26 is expressed on a restricted subpopulation of dendritic cells in vivo
Gliddon, D., & Howard, C. J. (2002) · European Journal of Immunology · Cited by 50
Geier, M. S., Tenikoff, D., Yazbeck, R., McCaughan, G. W., Abbott, C. A., & Howarth, G. S. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20333 · Cited by 48
Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis
Nishioka, T., Shinohara, M., Tanimoto, N., Kumagai, C., & Hashimoto, K. (2011) · Dermatology · doi:10.1159/000333358 · Cited by 47
A CD26-Controlled Cell Surface Cascade for Regulation of T Cell Motility and Chemokine Signals
Liu, Z., Christensson, M., Forslöw, A., Meester, I. D., & Sundqvist, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804336 · Cited by 46
Karl, T., Hoffmann, T., Pabst, R., & von Hörsten, S. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00154-0 · Cited by 44
Apical Secretion and Sialylation of Soluble Dipeptidyl Peptidase IV Are Two Related Events
Aït‐Slimane, T., Lenoir, C., Sapin, C., et al. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4894 · Cited by 44
Frerker, N., Raber, K. A., Bode, F. J., Skripuletz, T., Nave, H., Klemann, C., Pabst, R., Stephan, M., Schade, J., Brabant, G. E., et al. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.064 · Cited by 43
Self-citationHuman treg cells are characterized by low/negative CD6 expression
Santana, C. A. G., Tung, J. W., & Gulnik, S. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22513 · Cited by 42
Ibegbu, C., Xu, Y., Fillos, D., Radziewicz, H., Grakoui, A., & Kourtis, A. P. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02899.x · Cited by 42
Shingū, K., Helfritz, A., Zielinska‐Skowronek, M., Meyer‐Olson, D., Jacobs, R., Schmidt, R. E., Mentlein, R., Pabst, R., & von Hörsten, S. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0392-9 · Cited by 40
Kähne, T., Kröning, H., Thiel, U., Ulmer, A. J., Flad, H.-D., & Ansorge, S. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0134 · Cited by 40
Lun, S. W., Wong, C. K., Ko, F. W. S., Hui, D. S. C., & Lam, C. W. K. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9093-z · Cited by 40
Chung, K., Cheng, J., Suen, C., Huang, C., Tsai, C., Huang, L., Chen, Y., Wang, A. H. ‐., Jiaang, W., Hwang, M., et al. (2010) · Protein Science · doi:10.1002/pro.443 · Cited by 38
Wagner, L., Wolf, R., Zeitschel, U., Roßner, S., Petersén, Å., Leavitt, B. R., Kästner, F., Rothermundt, M., Gärtner, U., Gündel, D., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13378 · Cited by 38
Self-citationSmith, R. E., Talhouk, J. W., BROWN, E. E., & Edgar, S. E. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.851 · Cited by 38
Wrenger, S., Faust, J., Mrestani‐Klaus, C., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002338200 · Cited by 38
Steeg, C., Hartwig, U. F., & Fleischer, B. (1995) · Cellular Immunology · doi:10.1006/cimm.1995.1175 · Cited by 37
Davalos‐Misslitz, A. C. M., Bernhardt, G., & Förster, R. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00351.x · Cited by 37
Klemann, C., Schade, J., Pabst, R., Leitner, S., Stiller, J., von Hörsten, S., & Stephan, M. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03839.x · Cited by 36
Self-citationTricco, A. C., Antony, J., Khan, P. A., Ghassemi, M., Hamid, J. S., Ashoor, H. M., Blondal, E., Soobiah, C., Yu, C. H. Y., Hutton, B., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005752 · Cited by 36
Davoodi, J., Kelly, J., Gendron, N. H., & MacKenzie, A. (2007) · PROTEOMICS · doi:10.1002/pmic.200600654 · Cited by 35
Yamabe, T., TAKAKURA, K., Sugie, K., et al. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00230.x · Cited by 35
Delacour, D., Gouyer, V., Leteurtre, E., Aït‐Slimane, T., Drobecq, H., Lenoir, C., Moreau-Hannedouche, O., Trugnan, G., & Huet, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305755200 · Cited by 34
Batičić, L., Detel, D., Kučić, N., Buljević, S., Pugel, E. P., & Varljen, J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23261 · Cited by 34
NPY, NPY receptors, and DPP IV activity are modulated by LPS, TNF-α and IFN-γ in HUVEC
Silva, A. P., Cavadas, C., Baïsse, B., Spertini, O., Brunner, H. R., & Grouzmann, E. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00191-5 · Cited by 33
Structure of the mouse dipeptidyl peptidase IV (CD26) gene
Bernard, A., Mattéi, M., Pierres, M., & Marguet, D. (1994) · Biochemistry · doi:10.1021/bi00254a032 · Cited by 33
Erickson, R. H., Suzuki, Y., Sedlmayer, A., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36657-8 · Cited by 32
Ohnuma, K., Uchiyama, M., Hatano, R., Takasawa, W., Endo, Y., Dang, N. H., & Morimoto, C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.027 · Cited by 32
Regulation of the gene for human dipeptidyl peptidase IV by hepatocyte nuclear factor 1α
Erickson, R. H., Gum, J. R., LOTTERMAN, C. D., et al. (1999) · Biochemical Journal · doi:10.1042/bj3380091 · Cited by 30
Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
Saito, T., Ohnuma, K., Suzuki, H., Dang, N. H., Hatano, R., Ninomiya, H., & Morimoto, C. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.07.010 · Cited by 30
Dose-dependent recruitment of CD25+ and CD26+ T cells in a novel F344 rat model of asthma
Skripuletz, T., Schmiedl, A., Schade, J., Bedoui, S., Glaab, T., Pabst, R., von Hörsten, S., & Stephan, M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00273.2006 · Cited by 30
Self-citationSchmiedl, A., Krainski, J., Schwichtenhövel, F., Schade, J., Klemann, C., Raber, K. A., Zscheppang, K., Beekmann, T., Acevedo, C., Glaab, T., et al. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03547.x · Cited by 29
Self-citationYamashita, K., Tachibana, Y., Matsuda, Y., et al. (1988) · Biochemistry · doi:10.1021/bi00415a026 · Cited by 29
Schmidt, H., Gelhaus, C., Nebendahl, M., Lettau, M., Lucius, R., Leippe, M., Kabelitz, D., & Janßen, O. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-4 · Cited by 29
Gonzalez–Gronow, M., Misra, U. K., Gawdi, G., & Pizzo, S. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500383200 · Cited by 28
Jackson, E. K. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.158527 · Cited by 27
Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV
Detel, D., Pugel, E. P., Batičić, L., Buljević, S., & Varljen, J. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2011.061143 · Cited by 22
CD26+ T cells in the pathogenesis of asthma
Ohnuma, K., Yamochi, T., Hosono, O., & Morimoto, C. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02683.x · Cited by 20
Dipeptidyl Peptidase-4 Inhibition: Linking Chemical Properties to Clinical Safety
Matteucci, E., & Giampietro, O. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797535290 · Cited by 19
Insulin‐dependent phosphorylation of DPP IV in liver
Bilodeau, N., Fiset, A., Poirier, G. G., Fortier, S., Gingras, M., Lavoie, J. N., & Faure, R. L. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05125.x · Cited by 18
Volk, B., Kreisel, W., Köttgen, E., Gerok, W., & Reutter, W. G. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)81183-1 · Cited by 17
Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor
Mas-Vidal, A., Santos‐Juanes, J., Esteve-Martínez, A., Caminal‐Montero, L., & Coto‐Segura, P. (2011) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2011.00783.x · Cited by 17
Human Thymocyte Dipeptidyl Peptidase IV (CD26) Activity Is Altered with Stage of Ontogeny
Ruiz, P., Zacharievich, N., Lei, H. C., Viciana, A. L., & Shenkin, M. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4550 · Cited by 13
Airway-specific recruitment of T cells is reduced in a CD26-deficient F344 rat substrain
Schade, J., Schmiedl, A., Kehlen, A., Veres, T. Z., Stephan, M., Pabst, R., & von Hörsten, S. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03991.x · Cited by 13
Self-citationSerum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients
Delezuch, W., Marttinen, P., Kokki, M., Heikkinen, M., Vanamo, K., Pulkki, K. J., & Matinlauri, I. H. (2012) · Tissue Antigens · doi:10.1111/j.1399-0039.2012.01938.x · Cited by 13
Dipeptidyl Peptidases and Inflammatory Bowel Disease
Abbott, C. A., Yazbeck, R., Geier, M. S., Demuth, H., & Howarth, G. S. (2006) · Advances in experimental medicine and biology · doi:10.1007/0-387-32824-6_16 · Cited by 12
Ong, S. H., Blüher, M., & Schuetz, A. (2015) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s75935 · Cited by 11
Dipeptidyl peptidase IV (CD26) is a receptor for streptokinase on rheumatoid synovial fibroblasts
Gonzalez–Gronow, M., Weber, M. R., Gawdi, G., et al. (1998) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(98)80294-4 · Cited by 11
Stehling, P., Grams, S., Nuck, R., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1326 · Cited by 10
Cuchacovich, M., Gatica, H., Vial, P., Jorge Yovanovich, S., Pizzo, S. V., & Gonzalez–Gronow, M. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.6.1253-1259.2002 · Cited by 9
Micouin, A., & Bauvois, B. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9613-1_26 · Cited by 8
Grouzmann, E., & Buclin, T. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.101329 · Cited by 7
Cited by
Kulcsar, K. A., Coleman, C. M., Beck, S. E., & Frieman, M. B. (2019) · JCI Insight · doi:10.1172/jci.insight.131774 · Cited by 373
Xin, L., Gao, J., Zheng, Z., Chen, Y., Lv, S., Zhao, Z., Yu, C., Yang, X., & Zhang, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.648187 · Cited by 203
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00367-2 · Cited by 193
Lee, N., Heo, Y. J., Choi, S.-E., Jeon, J. Y., Han, S. J., Kim, D. J., Kang, Y., Lee, K. W., & Kim, H. J. (2021) · Journal of Immunology Research · doi:10.1155/2021/9944880 · Cited by 139
GLP-1 based therapies and disease course of inflammatory bowel disease
Villumsen, M., Schelde, A. B., Jimenez-Solem, E., Jess, T., & Allin, K. H. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.100979 · Cited by 97
Metadata
- Authors
- Klemann, C., Wagner, L., Stephan, M., & von Hörsten, S.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-05-13
- Volume
- 185
- Issue
- 1
- Pages
- 1-21
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W2276899615
- Cited by
- 425
- References
- 172
- FWCI
- 14.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.